OBN: Comprehensive Support for UK Bioscience Business via Networking, Partnering & Purchasing

$RSS - what\'s this? OBN web site information straight to your desktop - click to find out more$

Presentations are only available to member companies (Upgrade)
	Jamie Ferguson (Molecular shape recognition software Licensing Opportunity 2932)
	Kurt Laskow-Pooley (Key Notes on the Growth and Development of the Sector, OBN BioCluster Report 2008 - A Review of Key Findings)
	Patrick Baddeley (Preparing for Investment )
	Brian Cookson, RDP Associates (R&D Tax Relief Scheme)
	Suzanne Dilly (Magic Tag Immobilisation Technology for Chemical Genomics Approaches to Therapeutic Switching)
	Rob Swan (Exploring Sources of Business Intelligence for Biotech Deal Making)
	James Noble (A New Company in Adoptive T-cell Therapy)
	Nick Housby (Phage Therapy - A Novel Way of Preventing and Treating Bacterial Infections)
	Nick Housby (Phage Therapy - A Novel Way of Preventing and Treating Bacterial Infections)
	Melanie McCullagh (Pioneering a New Approach to Drug Discovery)
	Professor Thomas Sorensen (Lighting Up Biomedical Science)
	Dr John Barker, Evotec (Shining Diamond's Light on Fragment Drug Discovery)
	Dr Graham Cheetham, Vertex (Exploiting Diamond to Drive Drug Discovery of Challenging New Targets)
	Colin Love, SVP Product Development, BioVex (OncoVEX - To Phase III and Beyond )
	Scott Cuthill, Business Development Manager, Chroma Therapeutics (A Snapshot of the Oncology Pipeline )
	Simon McEwen, Director, Epidyme (Desensitisation to Autoimmune Diseases)
	Dr Kerry Fisher (Polymer Coated ???????Stealth' Viruses for Vaccine and Therapeutic Applications)
	Dr John Efthimiou, Phynova (Botanical Drugs: A New Pharmaceutical Paradigm)

date:	01/Jan/1970
time:
location:
address: